HP
44
3
KMX
61
3
BXP
54
-3
ROP
62
-3
COF
68
3
RL
78
-5
MOS
48
2
SHW
71
3
NEM
38
-4
BMY
64
21
PFG
48
5
GOOG
75
6
A
40
-3
MU
42
-4
WYNN
30
2
AON
60
-2
INTU
63
3
HCA
53
2
CMA
67
3
KSS
46
7
HP
44
3
KMX
61
3
BXP
54
-3
ROP
62
-3
COF
68
3
RL
78
-5
MOS
48
2
SHW
71
3
NEM
38
-4
BMY
64
21
PFG
48
5
GOOG
75
6
A
40
-3
MU
42
-4
WYNN
30
2
AON
60
-2
INTU
63
3
HCA
53
2
CMA
67
3
KSS
46
7
Financhill
Back

Beam Therapeutics Quote, Financials, Valuation and Earnings

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
73

BEAM
Beam Therapeutics

Last Price:
27.95
Seasonality Move:
54.38%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Beam Therapeutics Price Quote

$27.95
-2.43 (-8%)
(Updated: November 12, 2024 at 5:55 PM ET)

Beam Therapeutics Key Stats

Buy
73
Beam Therapeutics (BEAM) is a Buy
Day range:
$27.50 - $32.29
52-week range:
$18.85 - $49.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.11
P/B ratio:
3.18%
Volume:
1.8M
Avg. volume:
1.1M
1-year change:
37.09%
Market cap:
$2.5B
Revenue:
$377.7M
EPS:
$-1.76

How Much Does Beam Therapeutics Make?

Is Beam Therapeutics Growing As A Company?

  • What Is Beam Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.17%
  • What Is Beam Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Beam Therapeutics Stock Price Performance

What Is Beam Therapeutics 52-Week High & Low?

Beam Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Beam Therapeutics?

  • How Much Debt Does Beam Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Beam Therapeutics Have?
    Cash and short term investments quarterly total is $925.8M
  • What Is Beam Therapeutics’s Book Value Per Share?
    Book value per share is 9.58

Is Beam Therapeutics Cash Flow Positive?

  • What Is BEAM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$135.8M
  • What Is Beam Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $38M
  • What Is Beam Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $156.8M

Beam Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    BEAM return on invested capital is -16.62%
  • What Is Beam Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -10.97%
  • What Is BEAM Return On Equity?
    ROE is a measure of profitability and is -16.62%

Beam Therapeutics Earnings Date & Stock Price

Beam Therapeutics Competitors

Beam Therapeutics Dividend Yield

Beam Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0.93%
Revenue: -17.01% 0.97%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 8
Sell Recommendations: 0
Price Target: 49.20
Upside from Last Price: 61.95%

Major Shareholders

  • How many BEAM shares are owned by institutional investors?
    123.4M BEAM shares are owned by institutional investors
  • How many BEAM shares are owned by insiders?
    1.5M BEAM shares are owned by insiders